Evidence map›Paper›PMID 25611193›Full record

ArticlePrion2015

Amyloid-like assembly of the low complexity domain of yeast Nab3.

Thomas W O'Rourke, Travis J Loya, PamelaSara E Head, John R Horton, Daniel Reines

Open access · goldAbstract read
In one paragraph

Article in Prion, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Thomas W O'Rourkea Department of Biochemistry ; Emory University School of Medicine ; Atlanta , GA USA ;
Travis J Loya
PamelaSara E Head
John R Horton
Daniel Reines
AID Atlanta · USEmory University · US

Funding

PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008490 · NIGMS · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2022
$8.0M
Training Program in Biochemistry, Cell and Molecular BiologyT32GM008367 · NIGMS · EMORY UNIVERSITY · PI BOISE, LAWRENCE H., CORBETT, ANITA H. · 1990 to 2019
$5.6M
RNA POLYMERASE II ELONGATION COMPLEX--STRUCTURE/FUNCTIONR01GM046331 · NIGMS · EMORY UNIVERSITY · PI REINES, DANIEL · 1991 to 2013
$3.5M
FEI Transmission Electron Microscope with Tomography CapabilityS10RR025679 · NCRR · EMORY UNIVERSITY · PI SPEARMAN, PAUL W. · 2009 to 2009
$500k
NCRR NIH HHS S10RR025679NIGMS NIH HHS R01 GM046331NIGMS NIH HHS R01GM46331NIGMS NIH HHS T32 GM008367NIGMS NIH HHS T32GM008367NIGMS NIH HHS T32 GM008490
6 · The paper itself

Abstract

Termination of transcription of short non-coding RNAs is carried out in yeast by the Nab3-Nrd1-Sen1 complex. Nab3 and Nrd1 are hnRNP-like proteins that dimerize and bind RNA with sequence specificity. We show here that an essential region of Nab3 that is predicted to be prion-like based upon its sequence bias, formed amyloid-like filaments. A similar region from Nrd1 also assembled into filaments in vitro. The purified Nab3 domain formed a macroscopic gel whose lattice organization was observed by X-ray fiber diffraction. Filaments were resistant to dissociation in anionic detergent, bound the fluorescent dye thioflavin T, and showed a β-sheet rich structure by circular dichroism spectroscopy, similar to human amyloid β which served as a reference amyloid. A version of the Nab3 domain with a mutation that impairs its termination function, also formed fibers as observed by electron microscopy. Using a protein fragment interaction assay, the purified Nab3 domain was seen to interact with itself in living yeast. A similar observation was made for full length Nab3. These results suggest that the Nab3 and Nrd1 RNA-binding proteins can attain a complex polymeric form and raise the possibility that this property is important for organizing their functional state during termination. These findings are congruent with recent work showing that RNA binding proteins with low complexity domains form a dynamic subcellular matrix in which RNA metabolism takes place but can also aberrantly yield pathological aggregated particles.

Indexed as

Amino Acid SequenceAmyloid beta-PeptidesCircular DichroismElectrophoresis, Agar GelMolecular Sequence DataNuclear ProteinsProtein Structure, TertiaryRNA-Binding ProteinsSaccharomyces cerevisiae ProteinsSpectrometry, FluorescenceX-Ray DiffractionAmyloid beta-PeptidesNAB3 protein, S cerevisiaeNRD1 protein, S cerevisiaeNuclear ProteinsRNA-Binding ProteinsSaccharomyces cerevisiae ProteinsamyloidAβ, amyloid betaBSA, bovine serum albuminCPEB, cytoplasmic polyadenylation element binding proteinCTD, carboxy terminal domainDHFR, dihydrofolate reductaseDMSO, dimethyl sulfoxideEDTA, ethylenediaminetetraacetic acidfibrilGFP, green fluorescent proteinHFIP, hexafluoroisopropanolhnRNPhnRNP, heterogeneous nuclear ribonucleoproteinIPTG, isopropyl β-D-1-thiogalactopyranosidePCR, polymerase chain reactionRNA binding proteinRRM, RNA recognition motifSDD-AGE, semi-denaturing detergent agarose gel electrophoresisSDS, sodium dodecyl sulfateTEV, tobacco etch virustranscription termination

Identifiers

PMID25611193
PMCPMC4601387
OpenAlexW1500516246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.